Targeted surveillance strategies for efficient detection of novel antibiotic resistance variants.

Anti-Bacterial Agents / pharmacology Drug Resistance, Bacterial / drug effects Genome, Bacterial Gonorrhea / drug therapy Neisseria gonorrhoeae / drug effects
Neisseria gonorrhoeae antibiotic resistance diagnostic epidemiology global health infectious disease microbiology surveillance

Journal

eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614

Informations de publication

Date de publication:
30 06 2020
Historique:
received: 25 02 2020
accepted: 17 05 2020
entrez: 1 7 2020
pubmed: 1 7 2020
medline: 17 2 2021
Statut: epublish

Résumé

Genotype-based diagnostics for antibiotic resistance represent a promising alternative to empiric therapy, reducing inappropriate antibiotic use. However, because such assays infer resistance based on known genetic markers, their utility will wane with the emergence of novel resistance. Maintenance of these diagnostics will therefore require surveillance to ensure early detection of novel resistance variants, but efficient strategies to do so remain undefined. We evaluate the efficiency of targeted sampling approaches informed by patient and pathogen characteristics in detecting antibiotic resistance and diagnostic escape variants in

Identifiants

DOI: 10.7554/eLife.56367 PMID: 32602459 PMC: PMC7326491
pubmed: 32602459
doi: 10.7554/eLife.56367
pii: 56367
pmc: PMC7326491
doi:
pii:

Substances chimiques

Anti-Bacterial Agents 0

Banques de données

SRA
['SRP185594', 'ERP010312', 'DRP004052', 'SRP111927', 'ERP011192']

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI132606
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2020, Hicks et al.

Déclaration de conflit d'intérêts

AH, SK, TM, KM, GT, MA, DW, YG No competing interests declared, ML Reviewing editor, eLife

Références

Lancet Infect Dis. 2003 Jan;3(1):22-7
pubmed: 12505029
Lancet Planet Health. 2018 Sep;2(9):e398-e405
pubmed: 30177008
Euro Surveill. 2019 Sep;24(37):
pubmed: 31530345
J Clin Microbiol. 2019 Oct 23;57(11):
pubmed: 31511332
Elife. 2016 Mar 11;5:e14003
pubmed: 26974227
Sex Health. 2019 Sep;16(5):401-411
pubmed: 31505159
Diagn Microbiol Infect Dis. 2005 May;52(1):1-5
pubmed: 15878435
Euro Surveill. 2012 Mar 01;17(9):
pubmed: 22401563
Euro Surveill. 2019 Mar;24(10):
pubmed: 30862336
Eur J Clin Microbiol Infect Dis. 2004 Sep;23(9):705-10
pubmed: 15248092
Expert Rev Mol Diagn. 2017 Sep;17(9):845-859
pubmed: 28741392
Genome Res. 2009 Dec;19(12):2279-87
pubmed: 19901036
Clin Infect Dis. 2018 Sep 28;67(8):1294-1299
pubmed: 29659749
Genome Res. 2019 Feb;29(2):304-316
pubmed: 30679308
Sex Transm Infect. 2013 Dec;89 Suppl 4:iv47-51
pubmed: 24243880
Clin Infect Dis. 2018 Mar 5;66(6):818-824
pubmed: 29045605
Antibiotics (Basel). 2018 Jul 13;7(3):
pubmed: 30011825
Foodborne Pathog Dis. 2019 Jul;16(7):441-450
pubmed: 31194586
J Clin Microbiol. 2016 Mar;54(3):805-8
pubmed: 26739156
Sex Health. 2019 Sep;16(5):412-425
pubmed: 31437420
Antimicrob Agents Chemother. 2002 Sep;46(9):3020-5
pubmed: 12183262
Sex Transm Infect. 2020 May;96(3):204-210
pubmed: 32019895
Nat Genet. 2014 Mar;46(3):279-86
pubmed: 24464101
J Antimicrob Chemother. 2018 Feb 1;73(2):353-364
pubmed: 29182725
PLoS Pathog. 2019 May 13;15(5):e1007763
pubmed: 31083687
Nat Med. 2019 Dec;25(12):1858-1864
pubmed: 31768064
J Clin Microbiol. 2018 Jun 25;56(7):
pubmed: 29743311
Lancet Infect Dis. 2014 Mar;14(3):220-6
pubmed: 24462211
Emerg Infect Dis. 2019 Sep;25(9):1660-1667
pubmed: 31407661
Microb Genom. 2018 Aug;4(8):
pubmed: 30063202
Clin Microbiol Infect. 2011 Jun;17(6):815-20
pubmed: 21682802
Epidemiology. 2017 Jan;28(1):136-144
pubmed: 27748685
J Appl Microbiol. 2002;92 Suppl:78S-84S
pubmed: 12000616
J Clin Microbiol. 2002 Nov;40(11):4056-9
pubmed: 12409374
Nat Genet. 2015 Mar;47(3):242-9
pubmed: 25599400
PLoS Biol. 2019 Nov 12;17(11):e3000547
pubmed: 31714937
Nucleic Acids Res. 2019 Jun 20;47(11):5539-5549
pubmed: 31076776
J Infect Dis. 2017 Nov 27;216(9):1141-1149
pubmed: 28968710
Clin Microbiol Infect. 2017 Apr;23(4):267.e5-267.e7
pubmed: 27998822
Euro Surveill. 2011 May 26;16(21):
pubmed: 21632019
MMWR Morb Mortal Wkly Rep. 2007 Apr 13;56(14):332-6
pubmed: 17431378
J Clin Microbiol. 2004 Sep;42(9):4332-4
pubmed: 15365038
Emerg Infect Dis. 2008 Sep;14(9):1462-5
pubmed: 18760021
Nat Rev Microbiol. 2017 Nov;15(11):689-696
pubmed: 28757648
Ann N Y Acad Sci. 2019 Jan;1435(1):93-109
pubmed: 29876934
Nat Microbiol. 2019 Nov;4(11):1941-1950
pubmed: 31358980
J Clin Microbiol. 2001 Jun;39(6):2280-2
pubmed: 11376070
Microbiol Mol Biol Rev. 2015 Mar;79(1):101-16
pubmed: 25652543
Conserv Biol. 2010 Aug;24(4):1042-51
pubmed: 20184650
J Travel Med. 2019 Dec 23;26(8):
pubmed: 31115466
Emerg Infect Dis. 2012 Aug;18(8):1290-7
pubmed: 22840274
Nat Microbiol. 2020 Mar;5(3):455-464
pubmed: 32042129
J Comput Biol. 2012 May;19(5):455-77
pubmed: 22506599
New Microbes New Infect. 2015 Nov 27;9:58-62
pubmed: 26865983
Sex Transm Infect. 2019 Oct 5;:
pubmed: 31586947
Implement Sci. 2019 Aug 13;14(1):79
pubmed: 31409417
Nat Commun. 2019 Sep 5;10(1):3988
pubmed: 31488838
Bioinformatics. 2013 Apr 15;29(8):1072-5
pubmed: 23422339
Epidemiol Infect. 2009 Dec;137(12):1665-73
pubmed: 19493372
N Engl J Med. 1973 Jan 25;288(4):181-5
pubmed: 4264580
Sex Transm Dis. 2014 Apr;41(4):238-9
pubmed: 24622634
PLoS One. 2014 Nov 19;9(11):e112963
pubmed: 25409509
PLoS Biol. 2019 May 16;17(5):e3000250
pubmed: 31095567
Lancet Infect Dis. 2018 Jul;18(7):758-768
pubmed: 29776807
Genome Biol. 2016 Jun 20;17(1):132
pubmed: 27323842
J Antimicrob Chemother. 2018 Jul 1;73(7):1854-1861
pubmed: 29635367
Emerg Infect Dis. 2018 Mar;24(3):462-470
pubmed: 29460730
J Mol Biol. 1990 Oct 5;215(3):403-10
pubmed: 2231712
Nucleic Acids Res. 2004 Mar 19;32(5):1792-7
pubmed: 15034147
J Infect Dis. 2016 Nov 15;214(10):1579-1587
pubmed: 27638945
BMC Med. 2017 Jul 26;15(1):142
pubmed: 28747205
Nucleic Acids Res. 2015 Feb 18;43(3):e15
pubmed: 25414349

Auteurs

Allison L Hicks (AL)

Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, United States.
ORCID: 0000-0003-1372-1301

Stephen M Kissler (SM)

Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, United States.
ORCID: 0000-0003-3062-7800

Tatum D Mortimer (TD)

Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, United States.
ORCID: 0000-0001-6255-690X

Kevin C Ma (KC)

Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, United States.

George Taiaroa (G)

Department of Microbiology and Immunology, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.

Melinda Ashcroft (M)

Department of Microbiology and Immunology, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.

Deborah A Williamson (DA)

Department of Microbiology and Immunology, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
ORCID: 0000-0001-7363-6665

Marc Lipsitch (M)

Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, United States.
Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, United States.
ORCID: 0000-0003-1504-9213

Yonatan H Grad (YH)

Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, United States.
Division of Infectious Diseases, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, United States.
ORCID: 0000-0001-5646-1314

Articles similaires

Vancomycin-associated DRESS demonstrates delay in AST abnormalities.

Ahmed Hussein, Kateri L Schoettinger, Jourdan Hydol-Smith et al.
1.00
Humans Drug Hypersensitivity Syndrome Vancomycin Female Male

Management of the infected total elbow arthroplasty.

Joaquin Sanchez-Sotelo
1.00
Humans Arthroplasty, Replacement, Elbow Prosthesis-Related Infections Debridement Anti-Bacterial Agents

Comparative genomic analysis and characterization of novel high-quality draft genomes from the coal metagenome.

Arunmozhi Bharathi Achudhan, Lilly M Saleena
1.00
Coal Metagenome Phylogeny Bacteria Genome, Bacterial

Mathematical modeling of vancomycin release from Poly-L-Lactic Acid-Coated implants.

Papon Thamvasupong, Kwanchanok Viravaidya-Pasuwat
1.00
Vancomycin Polyesters Anti-Bacterial Agents Models, Theoretical Drug Liberation

Classifications MeSH

questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Anti-infectieux › Antibactériens › Targeted surveillance strategies for efficient...
questionsmedicales.fr › Phénomènes physiologiques › Phénomènes pharmacologiques et toxicologiques › Phénomènes pharmacologiques › Résistance aux substances › Résistance microbienne aux médicaments › Résistance bactérienne aux médicaments › Targeted surveillance strategies for efficient...
questionsmedicales.fr › Phénomènes génétiques › Structures génétiques › Génome › Génome microbien › Génome bactérien › Targeted surveillance strategies for efficient...
questionsmedicales.fr › Maladies urogénitales › Maladies génitales › Gonorrhée › Targeted surveillance strategies for efficient...
questionsmedicales.fr › Bactéries › Proteobacteria › Betaproteobacteria › Neisseriaceae › Neisseria › Neisseria gonorrhoeae › Targeted surveillance strategies for efficient...